Literature DB >> 8800457

Differences between 99mTc-DTPA and 99mTc-MAG3 captopril renographies in renovascular hypertension.

K Itoh1, Y Matsui, C Kato, T Mochizuki, A Kitabatake.   

Abstract

Captopril renography (CRS) with 99mTc-DTPA and 99mTc-MAG3 was performed on a 21-year-old woman with renovascular hypertension due to right renal artery stenosis caused by fibromuscular dysplasia. In the affected kidney, the renogram pattern was substantially changed with 99mTc-DTPA and 99mTc-MAG3 following the administration of captopril, and the quantitated renal uptake indicating individual renal function was significantly decreased in 99mTc-DTPA and slightly decreased in 99mTc-MAG3. In the contralateral normal kidney, the renogram showed some minor changes with both radioagents, while the quantitated renal uptake was significantly decreased with 99mTc-DTPA and substantially increased with 99mTc-MAG3. The combined use of physiologically different renal agents 99mTc-DTPA and 99mTc-MAG3 is helpful in investigating hemodynamic and functional changes in the stenosed kidney as well as the normal kidney in RVH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800457     DOI: 10.1007/bf03165401

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  18 in total

Review 1.  State-of-the-art review: captopril renography--pathophysiological considerations and clinical observations.

Authors:  J V Nally; H R Black
Journal:  Semin Nucl Med       Date:  1992-04       Impact factor: 4.446

2.  Captopril-enhanced 99Tcm-MAG3 renal scintigraphy in subjects with suspected renovascular hypertension.

Authors:  D Kahn; S Ben-Haim; D L Bushnell; M T Madsen; P T Kirchner
Journal:  Nucl Med Commun       Date:  1994-07       Impact factor: 1.690

3.  Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension.

Authors:  G N Sfakianakis; J J Bourgoignie; D Jaffe; G Kyriakides; E Perez-Stable; R C Duncan
Journal:  J Nucl Med       Date:  1987-09       Impact factor: 10.057

4.  Captopril renal scintigraphy: a new standard for predicting outcome after renal revascularization.

Authors:  G H Meier; B Sumpio; J F Setaro; H R Black; R J Gusberg
Journal:  J Vasc Surg       Date:  1993-02       Impact factor: 4.268

5.  Captopril renography and the hypertensive renal transplantation patient: a predictive test of therapeutic outcome.

Authors:  K K Shamlou; W E Drane; I F Hawkins; R S Fennell
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

6.  Comparison of two noninvasive screening tests for renovascular hypertension.

Authors:  W J Elliott; W B Martin; M B Murphy
Journal:  Arch Intern Med       Date:  1993-03-22

7.  Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Multicentre Study Group.

Authors:  E Fommei; S Ghione; A J Hilson; L Mezzasalma; H Y Oei; A Piepsz; D Volterrani
Journal:  Eur J Nucl Med       Date:  1993-07

8.  Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous).

Authors:  G F Gates
Journal:  AJR Am J Roentgenol       Date:  1982-03       Impact factor: 3.959

9.  Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.

Authors:  H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

Review 10.  Renovascular hypertension: etiology and pathophysiology.

Authors:  T G Pickering
Journal:  Semin Nucl Med       Date:  1989-04       Impact factor: 4.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.